BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - May 15, 2025

  May 16, 2025

   · 

  1 min read
• Press Releases

  Xuanzhu Biopharm’s Xuanyuening® (BireociclibTablets) Approved for Dual Indications, Bringing Innovative Breakthroughs to Breast Cancer Treatment

  May 16, 2025

   · 

  5 min read
• Press Releases

  InnoCare Announces First Patient Dosed in the Phase II/IIII Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Vitiligo in China

  May 16, 2025

   · 

  2 min read
• Press Releases

  Quarterly Report Q1 2025: Positive Outcome of Orviglance FDA Meeting in Advance of the NDA Submission

  May 16, 2025

   · 

  4 min read
• Press Releases

  Nordic Bioscience launches novel Endotrophin assay

  May 16, 2025

   · 

  3 min read
• Press Releases

  Shape Therapeutics Presents Preclinical Data Highlighting Therapeutic Potential of RNA Editing and AAV Delivery Platforms at the American Society of Gene and Cell Therapy 28th Annual Meeting

  May 16, 2025

   · 

  4 min read
• Press Releases

  CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting

  May 16, 2025

   · 

  10 min read
• Press Releases

  OS Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

  May 16, 2025

   · 

  8 min read
• Press Releases

  NanoViricides, Inc. Has Filed its Quarterly Report: Broad-Spectrum Antiviral NV-387 To Combat MPox Pandemic in Africa - Phase II Clinical Trial Update, Also Readying to Combat Measles Outbreaks, and to Tackle Bird Flu

  May 16, 2025

   · 

  16 min read
• Press Releases

  Merck to Present New Clinical and Outcomes Research Data at The American Thoracic Society’s (ATS) 2025 International Conference Demonstrating Commitment to Advancing Research in Pulmonary Arterial Hypertension

  May 16, 2025

   · 

  9 min read